{"transactions":[{"id":4637245,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-10-07T21:02:25.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":294,"price":1.99,"value":585.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 above reflects the weighted average price of 337 shares sold by a broker on October 5, 2026, to satisfy the payment of withholding tax liability of a group of employees of the Issuer, including the reporting person. The proceeds of all such sales were allocated to the employees, including the reporting person, on a pro rata basis."}],"balance_after":81715,"source":{"system":"sec-edgar","filing":"0000905148-26-004399","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841088/000090514826004399/form4.xml","form_type":"4"}},{"id":679555,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:09:33.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":185,"price":2.01,"value":371.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":82009,"source":{"system":"sec-edgar","filing":"0000905148-26-003839","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826003839/form4.xml","form_type":"4"}},{"id":703902,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-23T20:28:01.000Z","date":"2026-07-21","kind":"sale","planned":false,"acquired":false,"shares":573,"price":1.76,"value":1008.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":82194,"source":{"system":"sec-edgar","filing":"0000905148-26-003334","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826003334/form4.xml","form_type":"4"}},{"id":769401,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:30:36.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":49830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, 16.67% of the RSUs shall vest on November 18, 2026, and the remaining RSUs shall vest in 10 substantially equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":82767,"source":{"system":"sec-edgar","filing":"0000905148-26-002553","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826002553/form4.xml","form_type":"4"}},{"id":774268,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:11:25.000Z","date":"2026-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":1.92,"value":353.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":32937,"source":{"system":"sec-edgar","filing":"0000905148-26-002501","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826002501/form4.xml","form_type":"4"}},{"id":803494,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-21T21:05:48.000Z","date":"2026-04-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":1.78,"value":993.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":33121,"source":{"system":"sec-edgar","filing":"0000905148-26-001768","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826001768/form4.xml","form_type":"4"}},{"id":864768,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:19:56.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":129760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2027, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":129760,"derivative":{"exercise_price":1.51,"expiration_date":"2036-02-29","underlying":"Common Stock","underlying_shares":129760},"source":{"system":"sec-edgar","filing":"0000905148-26-001119","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826001119/form4.xml","form_type":"4"}},{"id":895594,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-18T21:12:42.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":217,"price":1.63,"value":353.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":33679,"source":{"system":"sec-edgar","filing":"0000905148-26-000937","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826000937/form4.xml","form_type":"4"}},{"id":933989,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-01-21T21:02:10.000Z","date":"2026-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":659,"price":1.98,"value":1304.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":33896,"source":{"system":"sec-edgar","filing":"0000905148-26-000281","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514826000281/form4.xml","form_type":"4"}},{"id":994999,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-11-18T21:32:18.000Z","date":"2025-11-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":2.24,"value":412.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":34555,"source":{"system":"sec-edgar","filing":"0000905148-25-004130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825004130/form4.xml","form_type":"4"}},{"id":1015108,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-21T20:06:48.000Z","date":"2025-10-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":1.81,"value":1009.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":34739,"source":{"system":"sec-edgar","filing":"0000905148-25-003637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825003637/form4.xml","form_type":"4"}},{"id":1023950,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-10-03T20:26:35.000Z","date":"2025-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":284,"price":1.81,"value":514.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":35297,"source":{"system":"sec-edgar","filing":"0000905148-25-003506","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825003506/form4.xml","form_type":"4"}},{"id":1063472,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-08-18T21:18:16.000Z","date":"2025-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":1.39,"value":255.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":35581,"source":{"system":"sec-edgar","filing":"0000905148-25-003042","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825003042/form4.xml","form_type":"4"}},{"id":1083801,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-07-21T20:28:26.000Z","date":"2025-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":1.32,"value":736.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":35765,"source":{"system":"sec-edgar","filing":"0000905148-25-002493","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825002493/form4.xml","form_type":"4"}},{"id":1144661,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-05-16T20:20:06.000Z","date":"2025-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":1.14,"value":209.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":36323,"source":{"system":"sec-edgar","filing":"0000905148-25-001823","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825001823/form4.xml","form_type":"4"}},{"id":1168968,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-04-18T19:51:24.000Z","date":"2025-04-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":1.81,"value":1009.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":36507,"source":{"system":"sec-edgar","filing":"0000905148-25-001257","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825001257/form4.xml","form_type":"4"}},{"id":1178617,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T20:32:43.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on April 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":15616,"derivative":{"exercise_price":1.68,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":15616},"source":{"system":"sec-edgar","filing":"0000905148-25-001076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825001076/form4.xml","form_type":"4"}},{"id":1225884,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T22:31:41.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":93693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":93693,"derivative":{"exercise_price":5.31,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":93693},"source":{"system":"sec-edgar","filing":"0000905148-25-000840","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825000840/form4.xml","form_type":"4"}},{"id":1258472,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:59:11.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":217,"price":5.42,"value":1176.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":37065,"source":{"system":"sec-edgar","filing":"0000905148-25-000729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825000729/form4.xml","form_type":"4"}},{"id":1297161,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-01-22T21:15:46.000Z","date":"2025-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":659,"price":5.78,"value":3809.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":37282,"source":{"system":"sec-edgar","filing":"0000905148-25-000168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514825000168/form4.xml","form_type":"4"}},{"id":1348791,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-27T23:11:14.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":67567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2025, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":67567,"derivative":{"exercise_price":5.7,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":67567},"source":{"system":"sec-edgar","filing":"0000905148-24-003295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824003295/form4.xml","form_type":"4"}},{"id":1361256,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-11-18T21:31:47.000Z","date":"2024-11-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":7.92,"value":1457.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":37941,"source":{"system":"sec-edgar","filing":"0000905148-24-003227","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824003227/form4.xml","form_type":"4"}},{"id":1383359,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-10-21T20:22:39.000Z","date":"2024-10-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":7.87,"value":4391.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":38125,"source":{"system":"sec-edgar","filing":"0000905148-24-002773","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824002773/form4.xml","form_type":"4"}},{"id":1391339,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-10-03T22:49:24.000Z","date":"2024-10-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":284,"price":6.98,"value":1982.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":38683,"source":{"system":"sec-edgar","filing":"0000905148-24-002637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824002637/form4.xml","form_type":"4"}},{"id":1430839,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-08-16T20:52:48.000Z","date":"2024-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":7.02,"value":1291.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":38967,"source":{"system":"sec-edgar","filing":"0000905148-24-002282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824002282/form4.xml","form_type":"4"}},{"id":1451019,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-07-19T20:20:31.000Z","date":"2024-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":7.69,"value":4291.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":39151,"source":{"system":"sec-edgar","filing":"0001140361-24-033600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000114036124033600/form4.xml","form_type":"4"}},{"id":1513698,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-05-16T23:03:54.000Z","date":"2024-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":184,"price":8.36,"value":1538.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":39709,"source":{"system":"sec-edgar","filing":"0000905148-24-001493","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824001493/form4.xml","form_type":"4"}},{"id":1538205,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-04-19T20:10:30.000Z","date":"2024-04-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":558,"price":10.34,"value":5769.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":39893,"source":{"system":"sec-edgar","filing":"0000905148-24-001186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824001186/form4.xml","form_type":"4"}},{"id":1637427,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-16T22:14:44.000Z","date":"2024-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":217,"price":3.4,"value":737.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":40451,"source":{"system":"sec-edgar","filing":"0000905148-24-000765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824000765/form4.xml","form_type":"4"}},{"id":1674913,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-19T21:24:20.000Z","date":"2024-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":652,"price":4.35,"value":2836.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":40668,"source":{"system":"sec-edgar","filing":"0000905148-24-000240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514824000240/form4.xml","form_type":"4"}},{"id":1738560,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-17T00:43:28.000Z","date":"2023-11-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":735,"price":5.08,"value":3733.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":41320,"source":{"system":"sec-edgar","filing":"0000905148-23-001477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514823001477/form4.xml","form_type":"4"}},{"id":1757343,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-10-19T23:45:41.000Z","date":"2023-10-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2232,"price":5.48,"value":12231.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units."}],"balance_after":42055,"source":{"system":"sec-edgar","filing":"0000905148-23-001156","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514823001156/form4.xml","form_type":"4"}},{"id":1771980,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-28T23:17:49.000Z","date":"2023-09-26","kind":"grant","planned":false,"acquired":true,"shares":11576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2024, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":11576,"derivative":{"exercise_price":8.95,"expiration_date":"2033-09-25","underlying":"Common Stock","underlying_shares":11576},"source":{"system":"sec-edgar","filing":"0000905148-23-001029","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514823001029/form4.xml","form_type":"4"}},{"id":1771979,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"officer":true,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-09-28T23:17:49.000Z","date":"2023-09-26","kind":"grant","planned":false,"acquired":true,"shares":3858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, twenty-five percent (25%) shall vest on October 1, 2024, and the remaining RSUs shall vest in three substantially equal annual installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":44287,"source":{"system":"sec-edgar","filing":"0000905148-23-001029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1781174/000090514823001029/form4.xml","form_type":"4"}},{"id":2318493,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Class A Common Stock","published_at":"2022-03-24T21:12:10.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":54789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 22, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Ms. Miller's continued service through the applicable vesting date."}],"balance_after":383512,"source":{"system":"sec-edgar","filing":"0001562180-22-002943","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000156218022002943/primarydocument.xml","form_type":"4"}},{"id":2343372,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Class A Common Stock","published_at":"2022-03-08T21:59:41.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":189655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 33% on March 4, 2023 with the remainder vesting in eight equal quarterly installments thereafter, subject to Ms. Miller's continued service through the applicable vesting date."}],"balance_after":328723,"source":{"system":"sec-edgar","filing":"0001104659-22-031597","document":"tm228660d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000110465922031597/tm228660d4_4.xml","form_type":"4"}},{"id":2387265,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-17T22:21:50.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":16677,"price":5.9515,"value":99253.1655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\")\nthat were granted on February 11, 2021 pursuant to a \"sell to cover\" provision included in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price per share. The shares sold at prices ranging from $5.75 to $6.05 per share. Full information regarding\nthe number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a\nsecurity holder of the Issuer."}],"balance_after":139068,"source":{"system":"sec-edgar","filing":"0001562180-22-001584","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000156218022001584/primarydocument.xml","form_type":"4"}},{"id":2831836,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and CS"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-25T21:05:11.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":259575,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in connection with the Merger in exchange for a stock option to acquire 250,000 shares of Butterfly common stock for $9.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as to 25% on December 31, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Miller's continued service through the applicable vesting date."}],"balance_after":259575,"derivative":{"exercise_price":9.4,"expiration_date":"2030-12-17","underlying":"Class A Common Stock","underlying_shares":259575},"source":{"system":"sec-edgar","filing":"0001104659-21-028226","document":"tm217907d1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000110465921028226/tm217907d1_4a.xml","form_type":"4/A","original_submission_date":"2021-02-16"}},{"id":2831835,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and CS"}}],"security":"Class A Common Stock","published_at":"2021-02-25T21:05:11.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":155745,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over four years beginning on February 11, 2022, subject to Ms. Miller's continued service through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of November 19, 2020, by and among Longview Acquisition Corp. (\"Longview\"), Clay Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Longview (\"Merger Sub\"), and Butterfly Network, Inc., a Delaware corporation (\"Butterfly\"), pursuant to which Merger Sub merged with and into Butterfly (the \"Merger\"), with Butterfly surviving as a wholly-owned subsidiary of Longview (which changed its name to \"Butterfly Network, Inc.\", the \"Issuer\"), these shares were received in exchange for 150,000 RSUs of Butterfly."}],"balance_after":155745,"source":{"system":"sec-edgar","filing":"0001104659-21-028226","document":"tm217907d1_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000110465921028226/tm217907d1_4a.xml","form_type":"4/A","original_submission_date":"2021-02-16"}},{"id":2858111,"issuer":{"id":4467,"kind":"organization","name":"Butterfly Network, Inc.","symbol":"BFLY"},"owners":[{"id":21132,"kind":"person","name":"Miller Mary","position":1,"cik":"0001841088","reported_name":"Miller Mary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC and CS"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-17T02:04:27.000Z","date":"2021-02-12","kind":"grant","acquired":true,"shares":259575,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of November 19, 2020, by and among Longview Acquisition Corp. (\"Longview\"), Clay Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Longview (\"Merger Sub\"), and Butterfly Network, Inc., a Delaware corporation (\"Butterfly\"), pursuant to which Merger Sub merged with and into Butterfly, with Butterfly surviving as a wholly-owned subsidiary of Longview (which changed its name to \"Butterfly Network, Inc.\", the \"Issuer\"), this stock option was received in exchange for a stock option to acquire 250,000 shares of Butterfly common stock for $9.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on December 31, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Miller's continued service through the applicable vesting date."}],"balance_after":259575,"derivative":{"exercise_price":9.4,"expiration_date":"2030-12-17","underlying":"Class A Common Stock","underlying_shares":259575},"source":{"system":"sec-edgar","filing":"0001104659-21-024563","document":"tm216719-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804176/000110465921024563/tm216719-20_4seq1.xml","form_type":"4"}}]}